Effect and safety of roflumilast for chronic obstructive pulmonary disease in Chinese patients

BACKGROUND: This trial aimed to evaluate the efficacy and safety of roflumilast for treating Chinese patients with chronic obstructive pulmonary disease (COPD). METHODS: A total of 120 patients with COPD were recruited and were randomly divided into 2 groups (an intervention group and a placebo grou...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Dong-yang, Wang, Zhi-guo, Gao, Yuan, Zhang, Hui-min, Zhang, Yu-xiang, Wang, Xiao-jun, Peng, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839818/
https://www.ncbi.nlm.nih.gov/pubmed/29443750
http://dx.doi.org/10.1097/MD.0000000000009864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839818/
https://www.ncbi.nlm.nih.gov/pubmed/29443750
http://dx.doi.org/10.1097/MD.0000000000009864

Ejemplares similares